Evidence map›Paper›PMID 40041375›Full record

ArticleRSC advances2025

Ultrasonic-assisted europium decorated cuprous oxide nanoparticles: exploring their photothermal capabilities and antioxidant properties for biomedical applications.

Sarmistha Mazumder, Tiasa Das, Raviraj Vankayala

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sarmistha MazumderCenter for Medical Technologies, Indian Institute of Technology Jodhpur 342030 Rajasthan India.
Tiasa DasDepartment of Bioscience & Bioengineering, Indian Institute of Technology Jodhpur 342030 Rajasthan India rvankayala@iitj.ac.in.
Raviraj VankayalaCenter for Medical Technologies, Indian Institute of Technology Jodhpur 342030 Rajasthan India.ORCID https://orcid.org/0000-0002-4661-066X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metal oxide nanoparticles offer capabilities for cancer therapeutics, but their applicability is often jeopardized due to toxicity hurdles. To tackle this problem, in this study, we have synthesized europium decorated cuprous oxide nanoparticles (Eu-Cu

Identifiers

PMID40041375
PMCPMC11877118

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.